Inivata
Edit

Inivata

https://www.inivata.com/
Last activity: 18.05.2023
Tags:CareInformationLegalTechMedtechNewsPlatformProductResearchTechnologyUniversity
Inivata is a leader in liquid biopsy. Its InVision® platform unlocks essential genomic information from a simple blood test to transform the care of cancer patients. The Company’s technology is based on pioneering research from the Cancer Research UK Cambridge Institute, University of Cambridge and backed by multiple high calibre publications. Its lead product, InVisionFirst™-Lung, is commercially available and provides molecular insights that enable clinicians to make more informed treatment decisions for NSCLC patients. Inivata is partnering with pharmaceutical and biotechnology companies on InVisionFirst-Lung and its wider platform, which is applicable to a range of cancer types. The Company has a CLIA laboratory in Research Triangle Park, NC and R&D laboratories in Cambridge, UK. For more information, please go to www.inivata.com. Follow us on Twitter @Inivata. For more information, please go to www.inivata.com. Follow us on Twitter @Inivata.
Location: United States, North Carolina, Morrisville
Member count: 51-200
Total raised: $139.354303M
Founded date: 2014

Investors 1

DateNameWebsite
18.05.2023Cambridge Inno...cic.vc

Funding Rounds 4

DateSeriesAmountInvestorsDeal News
09.02.2021Series C$35M-cambridgenetwo...
28.03.2019Series B$52.6M-finsmes.com/20...
26.01.2016Series A$45.198485M-finsmes.com/20...
23.09.2014-$6.555818M-finsmes.com/20...

Mentions in press and media 66

DateTitleDescriptionSource
15.09.2022Find your next...Calling all jobseekers! Don't miss Cambridge Network's Virtual Jobs & Careers Fair taking place ...cambridgenetwo...
01.08.2022Slone Partners...“Thomas Schlumpberger is an experienced and admired leader in the POC diagnostics field where he has...prweb.com/rele...
29.09.2021Entreprene...Entrepreneurial pathways to impact: spinning-out your research Hosted by Cambridge Innovation Capit...cic.vc/new...
18.06.2021NeoGenomic...NeoGenomics completes Inivata acquisition Combining best-in-class liquid biopsy technology with lea...cic.vc/new...
25.05.2021Inivata An...Inivata Announces Collaboration with F-star Therapeutics for the use of RaDaR™ Assay RaDaR ctDNA li...cic.vc/new...
05.05.2021US giant s...US giant swallows rest of Inivata in $415m acquisition Business Weekly article | By Tony Quested N...cic.vc/new...
05.05.2021Cambridge ...Cambridge Innovation Capital announces acquisition of portfolio company Inivata Cambridge Innovatio...cic.vc/new...
28.04.2021Inivata an...Inivata and Agendia sign agreement for commercialization of RaDaR® MRD liquid biopsy assay in breast...cic.vc/new...
10.04.2021Inivata pr...Inivata presents new data in support of its liquid biopsy technologies at AACR Virtual Annual Meetin...cic.vc/new...
09.03.2021FDA grants...FDA Grants Breakthrough Device Designation for Inivata’s RaDaR™ Assay Designation will help acceler...cic.vc/new...
Show more